Year
Edition number
№20 (333)№s5-16№19 (332)№18 (331)№16 (329)№s4-16№s3-16№15 (328)№14 (327)№13 (326)№12 (325)№11 (324)№10 (323)№9 (322)№8 (321)№7 (320)№6 (319)№5 (318)№4 (317)№3 (316)№s2-16№2 (315)№s1-16№1 (314)
№17 (330) / 2016
A.I. Semenova, S.A. Protsenko, A.V. Novik, D.H. Latipova, G.M. Teletayeva, T.Y. Semiglazova
ROLE OF NEW ANTIANGIOGENIC DRUGS IN THE SECOND-LINE TREATMENT OF NON-SMALL-CELL LUNG CANCER9-19
L.G. Zhukova, A.G. Manikhas
FIRST-LINE ENDOCRINE THERAPY OF HORMONE RECEPTOR-POSITIVE HER2-NEGATIVE METASTATIC BREAST CANCER. TIME OF CHANGE AFTER A LONG-TERM CALM PERIOD20-24
E.I. Borisova, S.L. Gutorov, M.E. Abramov
TREATMENT OF NON-SMALL CELL LUNG CANCER: THE NEXT STEP25-29
E.V. Artamonova (1), L.V. Bolotina (2), Zh. Gligorov (3), V.A. Gorbunova (1), N.V. Zhukov (4, 5), L.G. Zhukova (1), E.N. Imyanitov (6), E.V. Karabina (7), E.I. Kovalenko (1), M.R. Lichinitser (1), L.V. Manzyuk (1), V.F. Semiglazov (6, 8), T.Yu. Semiglazova (6, 8), D.L. Stroyakovsky (9)
RESOLUTION SUMMARIZING THE RESULTS OF THE EXPERT COUNCIL "MODERN APPROACHES TO THE TREATMENT OF HER2-NEGATIVE METASTATIC BREAST CANCER. PROSPECTS FOR THE USE OF ERIBULIN AS A PART OF COMBINATION THERAPY FOR BREAST CANCER"30-36
V.F. Semiglazov (1), G.A. Dashyan (1), V.V. Semiglazov (2), R.M. Paltuev (1), T.Yu. Semiglazova (1), R.V. Donskikh (1), K.S. Nikolaev (1), A.V. Komyakhov (1), K.Yu. Zernov (1), P.V. Krivorotko (1)
TAXANES IN THE TREATMENT OF BREAST CANCER37-42
A.S. Odintsova, V.A. Gorbunova, N.F. Orel, A.A. Markovich, A.E. Kuzminov, S.A. Polozkova, G.S. Emelyanova, A.A. Kuznetsova
THE USE OF SUNITINIB IN PANCREATIC NEUROENDOCRINE TUMORS: EXPERIENCE OF THE DEPARTMENT OF CHEMOTHERAPY FSBI RORC N.A. N.N. BLOKHIN OF RMH44-48
A.V. Smolin (1), E.V. Kryukov (1), A.V. Konev (1), S.N. Nikolaeva (1), Yu.E. Shamanskaya (1), A.V. Gorbacheva (2), A.G. Matveev (1)
OPTIMIZATION OF TREATMENT TACTICS USING TARGETED THERAPY IN METASTATIC AND LOCALLY ADVANCED SMALL CELL LUNG CANCER49-58
A.D. Kaprin, V.M. Khomyakov, A.B. Ryabov, L.V. Bolotina, A.V. Ivanov, A.B. Utkina, N.N.Volchenko
PRESSURIZED INTRAPERITONEAL AEROSOL CHEMOTHERAPY (PIAC) IN COMBINATION WITH SYSTEMIC CHEMOTHERAPY FOR STOMACH CANCER PATIENTS WITH PERITONEAL DISSEMINATION59-65
V.N. Korolyov (1), D.V. Gogoleva (2), E.V. Malakhova (2), O.A. Kurnosova (3)
ENDOSONOGRAPHY OF LUNGS AND MEDIASTINUM IN ONCOLOGY: FEATURES OF VERIFICATION OF THE DIAGNOSIS66-70
I.S. Varlamov (1, 2), S.A. Varlamov (1), A.F. Lazarev (1, 2)
PROSTATE-SPECIFIC ANTIGEN AS A CRITERION OF PROSTATE CANCER PROGRESSION AFTER RADICAL PROSTATECTOMY72-74
V.M. Khomyakov, S.S. Pirogov, A.V. Ivanov
NEUROENDOCRINE TUMORS OF THE STOMACH: CLASSIFICATION, DIAGNOSTICS, TREATMENT (LITERATURE REVIEW)75-81
M.E. Abramov, O.O. Gordeeva, E.I. Borisova, S.L. Gutorov, G.V. Vyshinskaya
NEW REALITIES IN THE TREATMENT OF DISSEMINATED SKIN MELANOMA WITH BRAF MUTATION82-86
N.V. Dobrova, E.I. Borisova, S.L. Gutorov, M.E. Abramov
WHETHER PRIMARY TUMOR LOCALIZATION IS IMPORTANT FOR THE PREDICTION OF DRUG TREATMENT OF METASTATIC COLON CANCER?87-91
D.R. Naskhletashvili
CLINICAL CASE O THE EFFECTIVE TREATMENT OF RELAPSE OF ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA WITH BRAF V600E MUTATION USING TARGET DRUG VEMURAFENIB92-94
M.E. Abramov (1), K.S. Bardovskaya (2), A.A. Mescheryakov (1), B.M. Medvedeva (1)
METASTATIC GASTRIC CANCER: DESCRIPTION OF CLINICAL CASE96-99
E.V. Trusilova, A.M. Ivanov, N.S. Besova, I.Yu. Skvortsov, N.Ts. Tsymzhitova
CLINICAL OBSERVATION OF RARE METASTASIS OF GASTRIC ADENOCARCINOMA TO THE PENIS100-103
